Quantcast

Latest Intravenous immunoglobulin Stories

2014-08-06 16:30:18

Three year demonstration project for Medicare Part B recipients will study the impact of paying for intravenous immunoglobulin (IVIG) home infusions TOWSON, Md., Aug. 6, 2014 /PRNewswire/ -- The Immune Deficiency Foundation (IDF) is pleased to announce that the enrollment for the Medicare IVIG Demonstration Project will begin on August 08, 2014. The enrollment period will end on September 12, 2014, so patients should act quickly to sign up. If approved, a beneficiary receiving an...

2014-07-28 12:27:34

TOTOWA, N.J., July 28, 2014 /PRNewswire/ -- BiologicTx(®) announced their Discovery 2 Life((TM)) (D2L((TM))), a leading digital health platform designed to guide and support hospitals, clinicians and patients throughout the organ transplant continuum. D2L supports aspects of the organ transplant process, including organization of data associated with enrolling a transplant candidate into a desensitization therapeutic program, donor data management (including identifying optimal...

2014-06-24 08:32:22

Interlaken Leadership Awards Program Supports Original Research in the Field of Neuroimmunology KING OF PRUSSIA, Pa., June 24, 2014 /PRNewswire/ -- CSL Behring announced today that Bart C. Jacobs, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, Netherlands, is the recipient of the 2014 Interlaken Leadership Awards for original research in the field of neuroimmunology. Established in 2010, this annual global awards program provides monetary grants and/or product supply for...

2014-02-25 12:27:56

DUBLIN, Feb. 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/ncdhtt/intravenous ) has announced the addition of the "Concise Analysis of the International Intravenous Immunoglobulin (IVIg) Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million. The report provides separate comprehensive analytics for the US, Canada,...

2013-10-07 23:28:14

As studies continue to reveal new data and clinical applications of IVIG, many questions and controversies regarding optimal therapeutic use remain unaddressed. It is critical for health plans to monitor ongoing and future studies, which may lead to new approved indications and more widespread acceptance of IVIG therapy. Portland, OR (PRWEB) October 07, 2013 In recent years, the clinical use of intravenous immunoglobulin (IVIG) therapy has expanded beyond its traditional place in the...

2013-09-26 23:02:12

Reportbuyer.com just published a new market research report: Global Intravenous Immunoglobulin (IVIg) Industry. London (PRWEB) September 26, 2013 This report analyzes the worldwide markets for Intravenous Immunoglobulin (IVIg) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these...

2013-08-17 23:02:27

Market Reports Online now offers Global IVIG Market Report: 2013 Edition research that provides an analysis of the world wide Intravenous immunoglobulin market with a special focus on the IVIG market of the US. Dallas, Texas (PRWEB) August 17, 2013 The Intravenous immunoglobulin (IVIG) market is characterized by fast pace developments in the clinical technology and testing methodology. Despite challenges like stringent regulations and high cost of treatment, the global IVIG market is all...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related